Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc V.LXG


Primary Symbol: LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Post by TanzaniteMotherLodeon Jan 22, 2021 4:31am
158 Views
Post# 32357166

To identify mutations labs have to create a full genomic seq

To identify mutations labs have to create a full genomic seq

B.C. laboratories are working on fast-tracking how they test for new, more infectious COVID-19 mutations, so that the province's recent success in flattening its pandemic curve is not quickly undone.
The province's seven-day average of new daily cases is hovering around 481 as of Thursday, but when it comes to genetic code a tiny change could be enough to alter a province's pandemic trajectory.

https://www.msn.com/en-ca/news/canada/b-c-labs-fast-tracking-tests-to-detect-new-more-infectious-covid-19-mutations/ar-BB1cYKW4?ocid=hplocalnews

<< Previous
Bullboard Posts
Next >>